Mochida Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The SDG assessment for Mochida Pharmaceutical Co Ltd indicates its reporting of the United Nations Sustainable Development Goals. This analysis of Mochida Pharmaceutical Co Ltd uses data points from across the web and also from available filings by Mochida Pharmaceutical Co Ltd. Other corporations in the rating industry group for Mochida Pharmaceutical Co Ltd are shown.
Mochida Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Mochida Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Mochida Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Mochida Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Mochida Pharmaceutical Co Ltd report the average age of the workforce?
Does Mochida Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Mochida Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Mochida Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Mochida Pharmaceutical Co Ltd offer flexible work?
Does Mochida Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Mochida Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Mochida Pharmaceutical Co Ltd conduct supply chain audits?
Does Mochida Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Mochida Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Mochida Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Mochida Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Mochida Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Mochida Pharmaceutical Co Ltd disclose water use targets?
Does Mochida Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Mochida Pharmaceutical Co Ltd have a product recall in the last two years?
Does Mochida Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Mochida Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Mochida Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Mochida Pharmaceutical Co Ltd disclose parental leave metrics?
Does Mochida Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Mochida Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Mochida Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Mochida Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Mochida Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Mochida Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Mochida Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Mochida Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Mochida Pharmaceutical Co Ltd disclose its waste policy?
Does Mochida Pharmaceutical Co Ltd report according to TCFD requirements?
Does Mochida Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Mochida Pharmaceutical Co Ltd disclose energy use targets?
Does Mochida Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Mochida Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Mochida Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.